7月6日，BrightSpring Health Services夜盘上涨5.52%，报72.84美元/股，成交额12.95万美元。
消息面上，美银证券将BrightSpring Health Services目标价从66美元大幅上调至77美元，维持买入评级，新目标价远高于市场平均目标价58.47美元。此次调升延续了多家投行对公司持续看好的趋势，此前UBS、德意志银行等也陆续上调目标价。基本面方面，公司一季度业绩表现强劲，调整后每股收益0.39美元，超出市场预期的0.31美元约26%，营收36.14亿美元同样超预期，公司随后上调了全年业绩指引。此外，公司6月宣布了同步股票回购计划，彰显管理层对长期价值的信心。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.